- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site San Diego, California, United States
- Novartis Investigative Site Ventura, California, United States
- Novartis Investigative Site Bradenton, Florida, United States
Clinical trial condition
Hepatitis C
Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.
1,296 public trials
40 recruiting studies
Hepatitis C trial results
Completed
Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects
NCT00807001
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C (HCV), +15 more
- Locations
-
Not specified
NCT01500616
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
- Locations
-
- Antwerp, Belgium
- Brussels, Belgium
- Charleroi, Belgium
- Ghent, Belgium
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
- Locations
-
- Saint Michael's Medical Center Newark, New Jersey, United States
Completed
Efficacy and Safety of Sofosbuvir+Ribavirin in Genotype 2 HCV-infected U.S. Veterans With Cirrhosis
NCT02128542
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
- Long Beach, California, United States
- Los Angeles, California, United States
- Palo Alto, California, United States
- San Diego, California, United States
NCT01559844
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Bronchial Diseases, +29 more
- Locations
-
- UCLA Medical Center-The Pfleger Liver Institute Los Angeles, California, United States
- UC San Diego San Diego, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado Aurora, Colorado, United States
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
- Locations
-
Not specified
NCT01330316
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
- Locations
-
- 1220.48.0004 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 1220.48.0091 Boehringer Ingelheim Investigational Site North Little Rock, Arkansas, United States
- 1220.48.0011 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 1220.48.0018 Boehringer Ingelheim Investigational Site Oceanside, California, United States
NCT01571583
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV) Infection, +15 more
- Locations
-
- Linz, Austria
- Vienna, Austria
- Brussels, Belgium
- Ghent, Belgium
NCT02216422
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV) Infection, +15 more
- Locations
-
Not specified